ArticleBritish journal of cancer2018

Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study.

Carmelo Tibaldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.